Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy

Dasatinib is a kinase inhibitor indicated for the treatment of newly diagnosed adults with Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase and accelerated (myeloid or lymphoid blast) phase, and CML with resistance or intolerance to prior therapy including imati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassin, Mohamed A, Nashwan, Abdulqadir J, Soliman, Ashraf T, Yousif, Anil, Moustafa, Afra, AlBattah, Afaf, Mohamed, Shehab F, Mudawi, Deena S, Elkourashy, Sarah, Asaari, Deena-Raiza, Gutierrez, Hope-Love G, Almusharaf, Mohamed, Hussein, Radwa M, Moustafa, Abbas H, Derhoubi, Hatim El, Boukhris, Sarra, Kohla, Samah, AlDewik, Nader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554353/
https://www.ncbi.nlm.nih.gov/pubmed/26379451
http://dx.doi.org/10.4137/CCRep.S25327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554353/
https://www.ncbi.nlm.nih.gov/pubmed/26379451
http://dx.doi.org/10.4137/CCRep.S25327

Ejemplares similares